Study of the RESS process for producing beclomethasone-17,21-dipropionate particles suitable for pulmonary delivery

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 39-46

  Charpentier, Paul A ^a   Jia, Ming ^a   Lucky, Rahima A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Asthma; Beclomethasone dipropionate; Crystallization; Micronization; Supercritical fluid processing

Indexed keywords

BECLOMETASONE DIPROPIONATE; NANOPARTICLE; ANTIASTHMATIC AGENT; BECLOMETASONE; MICROSPHERE;

ARTICLE; ASTHMA; CONTROLLED STUDY; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG PURITY; PARTICLE SIZE; PRESSURE MEASUREMENT; SUPERCRITICAL FLUID EXTRACTION; TEMPERATURE MEASUREMENT; AEROSOL; CHEMISTRY; INHALATIONAL DRUG ADMINISTRATION; METHODOLOGY; POWDER; ULTRASTRUCTURE;

ADMINISTRATION, INHALATION; AEROSOLS; ANTI-ASTHMATIC AGENTS; BECLOMETHASONE; CRYSTALLIZATION; DRUG COMPOUNDING; MICROSPHERES; NANOPARTICLES; PARTICLE SIZE; POWDERS;

EID: 44849116044     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-007-9004-x     Document Type: Article

References (33)

1. P. J. Barnes, S. Pedersen, and W. W. Busse. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 157(3):1-53 (1998).
2. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma, Update on Selected Topics 2002. Bethesda, MD. (2003).
3. H. S. Tan, and S. Borsadia. Particle formation using supercritical fluids: Pharmaceutical applications. Exp Opin Ther Patents. 11(5):861-872 (2001).
4. A. H. L. Chow, H. Y. Tong, P. Chattopadhyay, and B. Y. Shekunov. Particle engineering for pulmonary drug delivery. Pharm Res. 24(3):411-437 (2007).
5. N. Chew, and H.-K. Chan. Use of solid corrugated particles to enhance powder aerosol performance. Pharm Res. 18(11):1570 (2001).
6. M. P. Timsina, G. P. Martin, C. Marriott, D. Ganderton, and M. Yianneskis. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm. 101(1):1-13 (1994).
7. H.-K. Chan, P. M. Young, D. Traini, and M. Coates. Dry powder inhalers: challenges and goals for next generation therapies. Pharmaceutical Technology Europe. 19(4):19-24 (2007).
8. M. B. M. N. Dolovich, P. J. Anderson, C. A. Carmargo, N. Chew, C. H. Cole, R. Dhand, J. B. Fink, N. J. Gross, D. R. Hess, A. J. Hickey, C. S. Kim, T. B. Martonen, D. J. Pierson, B. K. Rubin, and G. C. Smaldone. Consensus statement: Aerosols and delivery devices. Respir Care. 45:589-596 (2000).
9. P. M. Young, D. Traini, M. Coates, and H. K. Chang. Recent advances in understanding the influence of composite-formulation properties on the performance of dry powder inhalers. Physica B 394:315-319 (2007).
10. H. K. Chan, and I. Gonda. Physicochemical characterization of a new respirable form of nedocromil. J Pharm Sci. 84:692-696 (1995).
11. J. G. Weers, T. E. Tarara, and A. R. Clark. Design of fine particles for pulmonary drug delivery. Expert Opin Drug Deliv. 4(3):297-313 (2007).
12. I. Pasquali, R. Bettini, and F. Giordano. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur J of Pharm Sci. 27:299-310 (2006).
13. C. Vemavarapua, M. J. Mollana, M. Lodayaa, and T. E. Needhamb. Design and process aspects of laboratory scale SCF particle formation systems. Int J Pharm. 292(1-2):1-16 (2005).
14. X. Ye, and C. M. Wai. Making nanomaterials in supercritical fluids: A review. J Chem Ed. 80(2):198-203 (2003).
15. C. Y. Tai, and C.-S. CHeng. Effect of CO2 on expansion and supersaturation of saturated solutions. AIChE J. 44(4):989-992 (1998).
16. R. K. Franklin, J. R. Edwards, Y. Chernyak, R. D. Gould, F. Henon, and R. G. Carbonell. Formation of perfluoropolyether coatings by the rapid expansion of supercritical solutions (RESS) process. Part 2: Numerical modeling. Ind Eng Chem Res. 40(26):6127-6139 (2001).
17. W. C. Hinds. Properties, Behavior, and Measurement of Airborne Particles, Second Edition. Wiley-Interscience, N.Y., USA., (1999).
18. R. M. Carter, and Y. Yan. Measurement of particle shape using digital imaging techniques. J Phys Conf Ser. 15:177-182 (2005).
19. B. K. Ku, M. S. Emergy, A. D. Maynard, M. R. Stolzenburg, and P. H. McMurry. In situ structure characterization of airborne carbon nanofibres by a tandem mobility-mass analysis. Nanotechnology. 17:3613-3621 (2006).
20. A. R. Martin, W. H. Finlay, M. J. Brett, and D. Vick. Generation and Recovery of Sub-Micron Diameter Fibrous Aerosols. Proceedings of the 2005 International Conference on MEMS, NANO, and Smart Systems. (2005).
21. Y. Bakhbakhi, P. A. Charpentier, and S. Rohani. Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery. Int J Pharm. 309(1-2):71 (2006).
22. A. Cacciuto, S. Auer, and D. Frenkel. Onset of heterogeneous crystal nucleation in colloidal suspensions. Nature. 428:404-406 (2004).
23. B. Helfgen, M. Turk, and K. Schaber. Hydrodynamic and aerosol modelling of the rapid expansion of supercritical solutions (RESS-process). J Supercrit Fluids. 26(3):225 (2003).
24. D. W. Matson, J. L. Fulton, R. C. Petersen, and R. D. Smith. Rapid Expansion of Supercritical Fluid Solution: Solute Formation of Powders, Thin Films and Fibers. Ind Eng Chem Res. 26:2298-2306 (1987).
25. P. G. Debenedetti, J. W. Tom, X. Kwauk, and S.-D. Yeo. Rapid expansion of supercritical solutions (RESS): Fundamentals and applications. Fluid Phase Equilib. 82:311-321 (1993).
26. S. Mawson, K. P. Johnston, J. R. Combes, and J. M. DeSimone. Formation of poly(1,1,2,2-tetrahydroperfluorodecyl acrylate) submicron fibers and particles from supercritical carbon dioxide solutions. Macromolecules. 28:3182-3191 (1995).
27. M. Turk, B. Helfgen, P. Hils, R. Lietzow, and K. Schaber. Micronization of pharmaceutical substances by rapid expansion of supercritical solutions (RESS): Experiments and modeling. Part Part Syst Charact. 19:327-335 (2002).
28. M. Charoenchaitrakool, F. Dehghani, N. R. Foster, and H. K. Chan. Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind Eng Chem Res. 39(12):4794-4802 (2000).
29. 2 and its micronization by RESS. J Supercrit Fluids. 6:241-248 (1993).
30. C. Domingo, E. Berends, and G. M. Van Rosmalen. Precipitation of ultrafine organic crystals from the rapid expansion of supercritical solutions over a capillary and a frit nozzle. J Supercrit Fluids. 10:35-55 (1997).
31. A. Sane, and M. C. Thies. The formation of fluorinated tetraphenylporphyrin nanoparticles via rapid expansion processes: RESS vs RESOLV. J Phys Chem B. 109(42):19688-19695 (2005). October 27, 2005
32. T. Hawa, and M. R. Zachariah. Coalescence kinetics of unequal sized nanoparticles. J Aerosol Sci. 37(1):1 (2006).
33. H. Larhrib, G. P. Martin, C. Marriott, and D. Prime. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharm. 257:283-296 (2003).